Rachele Berria
Vice President, Head of Medical US BioPharmaceuticals, AstraZeneca
Rachele Berria is Vice President and Medical Head of US Biopharmaceuticals at AstraZeneca. She leads the US Medical Team to ensure scientific leadership and a patient-centered approach throughout the Organization. Prior to her current role, she worked at Sanofi as Global Vice President and Medical Head of Diabetes and Primary care. Dr. Berria has been a key player in over 15 mechanisms of action-based therapies in both academic and industry settings. She is seen as a forerunner of randomized, pragmatic trials that mirror real world clinical decision making, draw cost-effectiveness measures, and foster collaboration with payers and large healthcare echo-systems. She has also been heavily involved in discovery, clinical development, and medical differentiation up to patient fruition. Dr. Berria received her Medical Degree and Ob-Gyn Board Certification from the University of Cagliari School of Medicine in Italy and completed a Fellowship in Diabetes and Metabolism at the University of Texas Health Science Center. She earned a Master of Science in Clinical Investigation from the University of Texas Health Science Center and her PhD in Medical Pathophysiology and Pharmacology at the University of Pisa School of Medicine, Italy.
